tradingkey.logo

Harvard Bioscience Inc

HBIO
0.753USD
-0.014-1.79%
收盤 12/19, 16:00美東報價延遲15分鐘
33.59M總市值
虧損本益比TTM

Harvard Bioscience Inc

0.753
-0.014-1.79%

關於 Harvard Bioscience Inc 公司

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Harvard Bioscience Inc簡介

公司代碼HBIO
公司名稱Harvard Bioscience Inc
上市日期Oct 21, 2013
CEODuke (John D)
員工數量330
證券類型Ordinary Share
年結日Oct 21
公司地址84 October Hill Rd
城市HOLLISTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編01746-1371
電話15088938999
網址https://www.harvardbioscience.com/
公司代碼HBIO
上市日期Oct 21, 2013
CEODuke (John D)

Harvard Bioscience Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
421.13K
+35.36%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
110.00K
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert Benson
Mr. Robert Benson
Independent Director
Independent Director
--
--
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
名稱
名稱/職務
職務
持股
持股變動
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
421.13K
+35.36%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
110.00K
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert Benson
Mr. Robert Benson
Independent Director
Independent Director
--
--
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Instruments, equipment, software and accessories
18.18M
88.89%
Service, maintenance and warranty contracts
2.27M
11.11%
地區USD
名稱
營收
佔比
United States
9.66M
47.22%
Europe, Middle East and Africa
6.59M
32.22%
China
2.45M
11.99%
Rest of Asia
1.33M
6.52%
Americas - Other
422.00K
2.06%
業務
地區
業務USD
名稱
營收
佔比
Instruments, equipment, software and accessories
18.18M
88.89%
Service, maintenance and warranty contracts
2.27M
11.11%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
AMH Equity, Ltd.
7.51%
Weber Capital Management, LLC
7.18%
Harvey Partners, LLC
4.60%
The Vanguard Group, Inc.
4.15%
Green (James W)
3.67%
其他
72.88%
持股股東
持股股東
佔比
AMH Equity, Ltd.
7.51%
Weber Capital Management, LLC
7.18%
Harvey Partners, LLC
4.60%
The Vanguard Group, Inc.
4.15%
Green (James W)
3.67%
其他
72.88%
股東類型
持股股東
佔比
Hedge Fund
17.67%
Investment Advisor
11.36%
Individual Investor
10.50%
Investment Advisor/Hedge Fund
10.39%
Venture Capital
7.18%
Pension Fund
2.04%
Research Firm
0.15%
Family Office
0.07%
Bank and Trust
0.01%
其他
40.63%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
201
25.97M
58.27%
-8.70M
2025Q2
214
34.64M
78.35%
-7.01M
2025Q1
216
35.57M
80.46%
-4.66M
2024Q4
216
39.38M
90.28%
+2.67M
2024Q3
217
37.20M
85.38%
-773.14K
2024Q2
216
36.12M
83.22%
-2.57M
2024Q1
216
36.60M
84.34%
-2.39M
2023Q4
219
36.53M
85.65%
-2.57M
2023Q3
223
36.90M
86.54%
-1.23M
2023Q2
223
36.47M
86.49%
-881.53K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
AMH Equity, Ltd.
4.05M
9.09%
+538.83K
+15.36%
Aug 06, 2025
Weber Capital Management, LLC
3.20M
7.19%
+683.45K
+27.15%
Mar 31, 2025
Harvey Partners, LLC
2.14M
4.81%
-46.40K
-2.12%
Jun 30, 2025
The Vanguard Group, Inc.
1.85M
4.16%
-284.86K
-13.32%
Jun 30, 2025
Green (James W)
1.64M
3.68%
-392.52K
-19.34%
Aug 15, 2025
272 Capital LLC
1.56M
3.49%
+1.56M
--
Sep 30, 2024
Acadian Asset Management LLC
1.04M
2.33%
-37.84K
-3.51%
Jun 30, 2025
Duke (John D.)
1.00M
2.25%
+1.00M
--
Aug 08, 2025
Meros Investment Management, LP
919.95K
2.07%
+125.27K
+15.76%
Jun 30, 2025
Florida State Board of Administration
910.00K
2.04%
+130.66K
+16.77%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Franklin US Small Cap Multifactor Index ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Lattice Hartford Multifactor Small Cap ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
Franklin US Small Cap Multifactor Index ETF
佔比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0%
Lattice Hartford Multifactor Small Cap ETF
佔比0%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0%
ProShares Hedge Replication ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
DFA Dimensional US Sustainability Core 1 ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Harvard Bioscience Inc的前五大股東是誰?

Harvard Bioscience Inc的前五大股東如下:
AMH Equity, Ltd.
持有股份:4.05M
佔總股份比例:9.09%。
Weber Capital Management, LLC
持有股份:3.20M
佔總股份比例:7.19%。
Harvey Partners, LLC
持有股份:2.14M
佔總股份比例:4.81%。
The Vanguard Group, Inc.
持有股份:1.85M
佔總股份比例:4.16%。
Green (James W)
持有股份:1.64M
佔總股份比例:3.68%。

Harvard Bioscience Inc的前三大股東類型是什麼?

Harvard Bioscience Inc 的前三大股東類型分別是:
AMH Equity, Ltd.
Weber Capital Management, LLC
Harvey Partners, LLC

有多少機構持有Harvard Bioscience Inc(HBIO)的股份?

截至2025Q3,共有201家機構持有Harvard Bioscience Inc的股份,合計持有的股份價值約為25.97M,占公司總股份的58.27% 。與2025Q2相比,機構持股有所增加,增幅為-20.08%。

哪個業務部門對Harvard Bioscience Inc的收入貢獻最大?

在FY2025Q2,Instruments, equipment, software and accessories業務部門對Harvard Bioscience Inc的收入貢獻最大,創收18.18M,占總收入的88.89% 。
KeyAI